MK0457, 50 mg

MK0457 is a small molecule Aurora kinase inhibitor widely used in stem cell biology and oncology research. This 50 mg vial is supplied for in vitro experimental workflows examining mitotic regulation, cell cycle progression, and proliferation control in cultured mammalian cells. The compound is typically reconstituted in DMSO to prepare stock solutions, with recommended storage at -20 degrees C to preserve activity across limited freeze-thaw cycles. Researchers apply MK0457 in cell culture models to probe phosphorylation events downstream of Aurora kinase A and Aurora kinase B, enabling investigation of chromosomal alignment, cytokinesis, and checkpoint signaling. Supplied by STEMCELL Technologies, each vial delivers consistent lot-to-lot purity suitable for reproducible signaling studies and dose-response assays. Working aliquots should be protected from light, and the powder handled with standard laboratory protective equipment to maintain compound integrity throughout experimental use.